Nevertheless, diabetes mellitus (yes vs. no) (HR: 2.543, P = 0.038), multivessel disease (yes vs. no) (HR: 4.281, P = 0.009), target vessel of RCA (vs. LAD) (HR: 4.494, P = 0.027), ACC/AHA type B2/C lesions (yes vs. no) (HR: 2.893, P = 0.040), TG (high vs. low) (HR: 2.855, P = 0.032), and CRP (high vs. low) (HR: 2.874, P = 0.041) were related to a higher MACE rate in DCB-treated SV-CAD patients. Here, CRP is linked to diabetes mellitus.